StonvexLoading…
StonvexStonvexStonvexCore line items from CNDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.04B | $3.36B | $3.72B | $3.86B |
Operating Income | $-160.00M | $504.00M | $-332.00M | $-127.00M |
Net Income | $-170.00M | $426.00M | $-296.00M | $-182.00M |
EPS (Diluted) | $-1.14 | $2.23 | $-1.41 | $-0.89 |
Total Assets | $2.40B | $2.60B | $3.16B | $3.57B |
Total Liabilities | $1.57B | $1.61B | $2.39B | $2.51B |
Cash & Equivalents | $233.00M | $366.00M | $498.00M | $582.00M |
Free Cash Flow OCF − CapEx | $-132.00M | $-78.00M | $38.00M | $52.00M |
Shares Outstanding | 154.71M | 161.83M | 211.51M | 218.35M |